The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results

9 Dec 2014 07:00

RNS Number : 1733Z
Image Scan Holdings PLC
09 December 2014
 



2014 Preliminary Results

IMAGE SCAN HOLDINGS PLC('Image Scan' or the 'Company')

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2014

Image Scan, an AIM-listed specialist in the field of real-time X-ray imaging for the security and industrial inspection markets, announces Preliminary Results for the year ended 30 September 2014.

KEY POINTS

· Delayed availability of an X-ray generator in the second half of the year, as announced most recently in the pre-close trading update of 9 October 2014, has led to a decline in financial performance and a full year loss of £451k (2013: loss of £297k)

· Order intake £1.5m (2013: £3.3m)

· Revenue down to £2.2m (2013: £2.5m)

· Labour costs down 17% to £820k (2013: £990k)

· Nuclear system delivered and accepted by customer

· Order for Axis checkpoint X-ray systems received from Saudi Arabia

· New board appointed and in place

· £945k gross raised to support increasing R&D and sales activity

POST YEAR-END EVENTS

· Distribution agreement signed with Sectus Technologies Inc. to extend market reach in North and South America

· First models of new portable X-ray generator received from US manufacturer and delivered to customers

· Development project launched for new check point X-ray product range

 

Bill Mawer, Chairman and Chief Executive of Image Scan, commented: "Having joined the Company in April it is frustrating to have to report such a loss after my first six months leading the business. The company had been working hard to find a replacement X-ray generator for its portable products following the loss of the previous supplier but, despite considerable focus on this area since my appointment, that situation was not rectified before the year end. I am however pleased to announce today that we have made the first customer deliveries of portable systems with the new generator, the superior performance of which is already exciting much customer interest.

The funds raised during the year are allowing us to accelerate our product development and marketing programme and the Board is looking forward to the launch of a number of exciting new products during the coming year. The recent extension of our market reach into North and South America will help drive uptake of these new products. "

-END-

Enquiries:

Image Scan Holdings plc Tel: +44 (0) 1509 817400Bill Mawer, Chairman and CEOir@ish.co.uk

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000David Foreman / Rick Thompson/Michael Reynolds (Corporate Finance)David Banks (Corporate Broking)

Yellow Jersey PR Limited Tel: +44 (0) 7747 788 221Anna Legge/Dominic Barretto

 

About Image Scan Holdings plc

Image Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time x-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the Axis range of baggage inspection systems; the FlatScan range of portable bomb and suspect package detection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet x-ray systems for laboratories and production lines. The Company was founded in 1996 and joined AIM in 2002.For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

CHAIRMAN AND CEO'S STATEMENT

INTRODUCTION

I am pleased to report on the results for Image Scan Group for the year ended 30 September 2014.

Order intake during 2014 totalled £1.5m (2013: £3.3million). Orders for portable X-ray systems were strong in the first half of the year but fell away in the second half of the year as the Company exhausted its remaining supply of the old style portable X-ray generators. The first half of the year also included the delivery of a Small Vehicle Inspection System (SVXI), the second of two systems for which orders were received in the prior year. Because of their high unit value, and the niche nature of the market, the presence or absence of sales of these systems exacerbates already uneven business performance in Image Scan. No new SVXI orders were received during the year. Revenue was £2.2m (2013: £2.5m), with 76% of sales being generated in the first half of the year.

In response to the decrease in activity in the prior year, operating costs were reduced in the year under review, with labour costs decreasing by 17% to £820k (2013: £990k). Within this reduced labour cost, internal research and development expenditure increased from £162k to £245k as resources released from the nuclear project were focussed on new product development. The business made a loss in the year of £451k (2013: loss of £297k).

The Company's performance has for some years been depressed by a large one-off contract in the nuclear industry. During the year this project generated revenue of £93k and a net loss of £85k. However during the year the system was delivered and accepted by the customer, an engineering company acting as system integrator. It is now installed at the final end user's site and the remaining tasks are limited to training and final setting to work. These are due for final completion by the end of January 2015. Only minimal involvement of the research and development team is expected to be required to achieve these final tasks.

A successful fund raising and subscription in September 2014 gave the Group a gross cash injection of £945k. This funding is being used to accelerate new product development in the portable X-ray and checkpoint X-ray areas and to expand the sales and marketing activity. At the year end the Group had a positive cash balance of £948k. (2013: £12k)

BUSINESS REVIEW

The sale of more than 40 portable X-ray systems in the first half of the year, points to the buoyant nature of the portable X-ray market. This is supported, in our view, by a continued and visible terrorist threat. In order to take advantage of this market strength the company is driving forward a product strategy that will give it a competitive system in each of the three price/technology sub segments. Only one competitor has as broad a product range. The first element of this strategy is the development of a replacement generator by our US partner. While it was frustrating not to have this before the year end, first production units have now been received and volume deliveries will start in January 2015. This will be the first of a series of new product releases within the portable X-ray range.

The Company is currently in the project definition phase of a programme aimed at replacing the Axis check point X-ray system with a new range of highly competitive systems built around a core X-ray architecture that already exists in prototype form. Formal launch of the development programme is due in January 2015.

In recent years, the Company has created good access to markets in the Middle East and parts of Asia. The first step has now been taken in the expansion of this route to market and the Company now has a very experienced partner in the important markets of Canada, the Caribbean and South America. New initiatives are underway to strengthen the Company's ability to reach European customers.

The Board will continue to focus investment and resources on new product development and the expansion of the route to market while maintaining a tight focus on overhead cost and operational performance. Management of cash will be particularly important in order to ensure the recently raised funds are focussed on growth projects rather than operational expenses.

FINANCIAL RESULTS

Revenue in the year ended 30 September 2014 of £2.2m (2013: £2.5m) was derived 70% from the security sector and 30% from the industrial sector. Security revenue of £1.4m was generated in the first half (£0.1m in the second half) reflecting the loss of portable X-ray system sales from mid-year. In addition to the sale of over 40 portable X-ray systems, the first half year's performance was underpinned by the sale of a Small Vehicle Inspection System.

Gross margin was 31% (2013: 37%). Margin on security products at 29% was depressed by a large portable X-ray contract taken at lower than normal margin. Margin on portable X-ray systems is expected to return to more normal levels (typically 35-40%) with the launch of the new portable products. Gross margin on industrial products was 34%. A further contributor to low gross margin was the additional and unforeseen cost experienced in the late stages of the nuclear contract, where sales of £93k yielded a net loss of £85k. However significant milestones were achieved, notably the acceptance of the system by the customer and delivery to the end user's site.

Downward pressure was exerted on costs with overheads being reduced to £1.2m, following a reduction of £300k to £1.3m in 2013. Despite the need to operate within this lower overhead the Company was able to increase the focus on internal research and development with spend increasing to £245k (2013: £162k). This 51% increase was facilitated by the release of resources from the nuclear contract.

The Group traded at close to break-even in the first half of the year with a loss of £36k on sales of £1.7m. The decline in security sales in the second half of the year led to a full year loss of £451k (2013: loss of £297k). The loss per share was 0.57p (2013: loss per share 0.39p).

The closing order book was £482k, (2013: £1.1m) supported by the award in September 2014 of a contract for £250k for multiple Axis checkpoint X-ray systems for Saudi Arabia.

The year-end cash balance was £948k (2013: £12k).

OUTLOOK

The new US sourced portable X-ray generator will be initially offered with the Company's current detector panel and software, to be replaced during the first half of the year by a new higher performance panel and new image processing software. This will be supplemented by a bought in medical-type detector panel for customers demanding the very highest image quality. A separate programme will lead to a lower cost system allowing the company to address, for the first time, a group of customers with lower budgets. The development of the replacement Axis checkpoint X-ray systems is in project definition phase and will continue through the year with product launch not expected until financial year 2014/15. Customer demonstrations of the new portable products have started and will continue through the year, both in established markets and in support of the planned geographical expansion of the Company's activity.

STAFF

The Company intends to adopt a performance related reward strategy with the introduction of a profit-based staff bonus scheme and the issue of share options to incentivise staff and to promote good staff retention.

The Board values greatly the considerable efforts made by our staff and I would like to take this opportunity to personally thank staff and shareholders for their continued commitment to the Company.

 

Bill MawerChairman and Chief Executive Officer9 December 2014 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

2014

£

2013

£

Continuing operations

REVENUE

2,194,735

2,537,786

Cost of sales

(1,521,574)

(1,586,820)

 

 

Gross profit

673,161

950,966

Administrative expenses

(1,196,969)

 (1,292,856)

 

 

OPERATING LOSS

(523,808)

(341,890)

Finance income

450

 

80

-

 

 

LOSS BEFORE TAXATION

(523,358)

(341,810)

Taxation

71,894

45,155

 

 

LOSS AND TOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE PARENT COMPANY

 

 

 

(451,464)

 

(296,655)

 

 

Pence

Pence

Earnings per share

Basic and diluted loss per share

(0.57)

(0.39)

 

 

 

IAS 33 requires presentation of diluted earnings per share ('EPS') when a company could be called upon to issue shares that would decrease net profit or increase net loss per share. Earnings or loss per share would not be affected by the exercise of out-of-the-money options since it is inappropriate to assume that option holders would act irrationally. Accordingly as there are no other diluting future share issues, diluted EPS equals basic EPS. 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

2014

£

2013

£

NON-CURRENT ASSETS

Property, plant and equipment

8,382

21,987

 

 

8,382

21,987

CURRENT ASSETS

Inventories

330,826

458,898

Trade and other receivables

182,121

1,119,944

Cash and cash equivalents

948,281

11,573

Current tax asset

71,894

36,064

 

 

1,533,122

1,626,479

 

 

TOTAL ASSETS

1,541,504

1,648,466

 

 

CURRENT LIABILITIES

Trade and other payables

363,821

927,795

Warranty provision

21,507

43,151

 

 

385,328

970,946

 

 

 

NET ASSETS

 

1,156,176

 

677,520

 

 

EQUITY

Share capital

1,256,046

762,679

Share premium account

7,934,528

7,501,105

Retained earnings

(8,034,398)

(7,586,264)

 

 

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

 

1,156,176

 

 

677,520

 

 

 

 

CONSOLIDATED STATEMETN OF CHANGES IN EQUITY

GROUP

Share capital

£

Share premium

£

Retained earnings

£

 

Total

£

As at 1 October 2012

762,679

7,501,105

(7,287,045)

976,739

Loss for the year

-

-

(296,655)

(296,655)

Share-based transactions

-

-

(2,564)

(2,564)

 

 

 

 

As at 30 September 2013

762,679

7,501,105

(7,586,264)

677,520

Shares issued during the year

Shares issued during the year in payment of creditors

Share issue costs

Loss for the year

479,908

13,459

-

-

490,093

21,291

(77,961)

-

-

-

-

(451,464)

970,001

34,750

(77,961)

(451,464)

Share-based transactions

-

-

3,330

3,330

 

 

 

 

As at 30 September 2014

1,256,046

7,934,528

(8,034,398)

1,156,176

 

 

 

 

 CONSOLIDATED CASH FLOW STATEMENT

2014

£

2013

£

Cash flows from operating activities

Operating loss

(523,808)

(341,890)

Adjustments for:

Depreciation

Impairment of inventories

13,348

44,631

21,472

-

Transfer of fixed assets to inventories

Loss on disposal of fixed assets

5,681

799

4,293

-

Decrease/(increase) in inventories

83,441

(45,948)

Decrease in trade and other receivables

937,823

1,546

(Decrease)/increase in trade and other payables

(585,618)

224,252

Share-based payments

38,080

(2,564)

 

 

Net cash from/(used in) operating activities

14,377

(138,839)

Corporation tax recovered

36,064

85,068

 

 

Net cash flows from operating activities

50,441

(53,771)

 

 

Cash flows from investing activities

Interest received

450

80

Purchase of property, plant and equipment

(6,223)

(8,518)

 

 

Net cash used in investing activities

 (5,773)

 (8,438)

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issue of share capital

970,001

-

Financial costs of Fundraising

(77,961)

-

 

 

Net cash from financing activities

 892,040

-

 

 

Net INCREASE/(DECREASE) in cash and cash equivalents

936,708

(62,209)

Cash and cash equivalents at beginning of year

11,573

73,782

 

 

Cash and cash equivalents at end of year

12

948,281

11,573

 

 

Notes to the preliminary statement1 Basis of preparation

The financial information set out above does not constitute the Company's statutory accounts for the years ended 30 September 2014 and 30 September 2013 but is derived from those accounts. Statutory accounts for 2013 have been delivered to the Registrar of Companies, and those for 2014 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under Section 498 of the Companies Act 2006.

2 IFRS 2 'Share-based payments'

Operating expenses includes a charge of £3,330 (2013 credit: £2,564) after valuation of the Company's employee share options schemes in accordance with IFRS 2 'Share-based payments'. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These items have been added back in the statement of changes in equity.

 

 

 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UGGQAPUPCGQR
Date   Source Headline
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.